
Daniel M. Huse, MA
Advertisement
Articles by Daniel M. Huse, MA
Advertisement
Latest Updated Articles
Impact of Leflunomide Versus Biologic Agents on the Costs of Care for Rheumatoid Arthritis in a Managed Care PopulationPublished: May 1st 2002 | Updated:
Use of Managed Care Claims Data in the Risk Assessment of Venous Thromboembolism in OutpatientsPublished: January 1st 2002 | Updated:
Outpatient Treatment of Venous Thromboembolism with Low-Molecular-Weight Heparin: An Economic EvaluationPublished: January 1st 2002 | Updated:
Anti-inflammatory Therapy Reduces Total Costs of Asthma Care Compared with Bronchodilation: The Asthma Outcomes RegistryPublished: September 1st 2000 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”
3
Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP
4
Asundexian Reduces Risk of Stroke Recurrence in Phase 3 OCEANIC-STROKE Trial
5



